Cigna Investments Inc. New Has $235,000 Stock Holdings in Mettler-Toledo International, Inc. $MTD

Cigna Investments Inc. New trimmed its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 6.1% in the 2nd quarter, HoldingsChannel reports. The firm owned 200 shares of the medical instruments supplier’s stock after selling 13 shares during the quarter. Cigna Investments Inc. New’s holdings in Mettler-Toledo International were worth $235,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in shares of Mettler-Toledo International by 1.2% during the first quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier’s stock valued at $3,003,485,000 after purchasing an additional 30,535 shares during the last quarter. Alliancebernstein L.P. lifted its holdings in shares of Mettler-Toledo International by 21.6% during the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock valued at $837,653,000 after purchasing an additional 126,147 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Mettler-Toledo International by 5.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier’s stock valued at $568,032,000 after purchasing an additional 25,272 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Mettler-Toledo International by 11.9% during the first quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier’s stock valued at $479,673,000 after purchasing an additional 43,082 shares during the last quarter. Finally, GAMMA Investing LLC lifted its holdings in shares of Mettler-Toledo International by 131,246.3% during the first quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier’s stock valued at $456,018,000 after purchasing an additional 385,864 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently commented on MTD shares. Robert W. Baird upped their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a report on Monday, August 4th. Bank of America upped their price target on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research report on Monday. Barclays assumed coverage on Mettler-Toledo International in a research report on Tuesday, June 24th. They set an “overweight” rating and a $1,325.00 price target on the stock. Evercore ISI dropped their price target on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating on the stock in a research report on Monday, August 4th. Finally, Citigroup upped their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research report on Thursday, August 21st. Five investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $1,325.56.

Insiders Place Their Bets

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of the company’s stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total value of $376,227.00. Following the transaction, the chief financial officer directly owned 5,095 shares of the company’s stock, valued at $6,389,588.55. This represents a 5.56% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Thomas P. Salice sold 1,062 shares of the company’s stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the sale, the director owned 283 shares of the company’s stock, valued at approximately $368,154.70. This trade represents a 78.96% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,827 shares of company stock valued at $2,371,208 in the last three months. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Price Performance

Shares of MTD stock opened at $1,210.34 on Friday. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,521.01. The stock’s 50-day moving average is $1,269.11 and its two-hundred day moving average is $1,185.26. The firm has a market cap of $24.93 billion, a P/E ratio of 30.65, a PEG ratio of 3.73 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. During the same period in the prior year, the firm posted $9.65 EPS. The business’s revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, research analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.